table of content
1 Introduction to Research & Analysis Reports
1.1 Precision Cancer Diagnostic Tests Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Diagnostic Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Precision Cancer Diagnostic Tests Overall Market Size
2.1 Global Precision Cancer Diagnostic Tests Market Size: 2021 VS 2028
2.2 Global Precision Cancer Diagnostic Tests Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Diagnostic Tests Players in Global Market
3.2 Top Global Precision Cancer Diagnostic Tests Companies Ranked by Revenue
3.3 Global Precision Cancer Diagnostic Tests Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Diagnostic Tests Companies in Global Market, by Revenue in 2021
3.5 Global Companies Precision Cancer Diagnostic Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Diagnostic Tests Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Diagnostic Tests Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Precision Cancer Diagnostic Tests Market Size Markets, 2021 & 2028
4.1.2 Imaging
4.1.3 Molecular
4.1.4 Histology/Cytology
4.1.5 Tumor Marker Immunoassays
4.1.6 POC Colon Cancer Tests
4.2 By Type - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
4.2.1 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
4.2.2 By Type - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
4.2.3 By Type - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Precision Cancer Diagnostic Tests Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
5.2.1 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
5.2.2 By Application - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
5.2.3 By Application - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Precision Cancer Diagnostic Tests Market Size, 2021 & 2028
6.2 By Region - Global Precision Cancer Diagnostic Tests Revenue & Forecasts
6.2.1 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2017-2022
6.2.2 By Region - Global Precision Cancer Diagnostic Tests Revenue, 2023-2028
6.2.3 By Region - Global Precision Cancer Diagnostic Tests Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Precision Cancer Diagnostic Tests Revenue, 2017-2028
6.3.2 US Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.3.3 Canada Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.3.4 Mexico Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Precision Cancer Diagnostic Tests Revenue, 2017-2028
6.4.2 Germany Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4.3 France Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4.4 U.K. Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4.5 Italy Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4.6 Russia Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4.7 Nordic Countries Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.4.8 Benelux Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Precision Cancer Diagnostic Tests Revenue, 2017-2028
6.5.2 China Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.5.3 Japan Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.5.4 South Korea Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.5.5 Southeast Asia Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.5.6 India Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Precision Cancer Diagnostic Tests Revenue, 2017-2028
6.6.2 Brazil Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.6.3 Argentina Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Precision Cancer Diagnostic Tests Revenue, 2017-2028
6.7.2 Turkey Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.7.3 Israel Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.7.4 Saudi Arabia Precision Cancer Diagnostic Tests Market Size, 2017-2028
6.7.5 UAE Precision Cancer Diagnostic Tests Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
7.1.4 Abbott Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Agilent Technologies
7.2.1 Agilent Technologies Corporate Summary
7.2.2 Agilent Technologies Business Overview
7.2.3 Agilent Technologies Precision Cancer Diagnostic Tests Major Product Offerings
7.2.4 Agilent Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.2.5 Agilent Technologies Key News
7.3 Becton Dickinson and Company
7.3.1 Becton Dickinson and Company Corporate Summary
7.3.2 Becton Dickinson and Company Business Overview
7.3.3 Becton Dickinson and Company Precision Cancer Diagnostic Tests Major Product Offerings
7.3.4 Becton Dickinson and Company Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.3.5 Becton Dickinson and Company Key News
7.4 Bio-Rad Laboratories
7.4.1 Bio-Rad Laboratories Corporate Summary
7.4.2 Bio-Rad Laboratories Business Overview
7.4.3 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Major Product Offerings
7.4.4 Bio-Rad Laboratories Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.4.5 Bio-Rad Laboratories Key News
7.5 Biocartis N.V.
7.5.1 Biocartis N.V. Corporate Summary
7.5.2 Biocartis N.V. Business Overview
7.5.3 Biocartis N.V. Precision Cancer Diagnostic Tests Major Product Offerings
7.5.4 Biocartis N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.5.5 Biocartis N.V. Key News
7.6 Biocept
7.6.1 Biocept Corporate Summary
7.6.2 Biocept Business Overview
7.6.3 Biocept Precision Cancer Diagnostic Tests Major Product Offerings
7.6.4 Biocept Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.6.5 Biocept Key News
7.7 bioMerieux SA
7.7.1 bioMerieux SA Corporate Summary
7.7.2 bioMerieux SA Business Overview
7.7.3 bioMerieux SA Precision Cancer Diagnostic Tests Major Product Offerings
7.7.4 bioMerieux SA Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.7.5 bioMerieux SA Key News
7.8 Canon Medical Systems Corporation
7.8.1 Canon Medical Systems Corporation Corporate Summary
7.8.2 Canon Medical Systems Corporation Business Overview
7.8.3 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Major Product Offerings
7.8.4 Canon Medical Systems Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.8.5 Canon Medical Systems Corporation Key News
7.9 Cynvenio Biosystems
7.9.1 Cynvenio Biosystems Corporate Summary
7.9.2 Cynvenio Biosystems Business Overview
7.9.3 Cynvenio Biosystems Precision Cancer Diagnostic Tests Major Product Offerings
7.9.4 Cynvenio Biosystems Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.9.5 Cynvenio Biosystems Key News
7.10 Danaher Corporation
7.10.1 Danaher Corporation Corporate Summary
7.10.2 Danaher Corporation Business Overview
7.10.3 Danaher Corporation Precision Cancer Diagnostic Tests Major Product Offerings
7.10.4 Danaher Corporation Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.10.5 Danaher Corporation Key News
7.11 Epigenomics AG
7.11.1 Epigenomics AG Corporate Summary
7.11.2 Epigenomics AG Business Overview
7.11.3 Epigenomics AG Precision Cancer Diagnostic Tests Major Product Offerings
7.11.4 Epigenomics AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.11.5 Epigenomics AG Key News
7.12 Exosome Diagnostics
7.12.1 Exosome Diagnostics Corporate Summary
7.12.2 Exosome Diagnostics Business Overview
7.12.3 Exosome Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
7.12.4 Exosome Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.12.5 Exosome Diagnostics Key News
7.13 Foundation Medicine
7.13.1 Foundation Medicine Corporate Summary
7.13.2 Foundation Medicine Business Overview
7.13.3 Foundation Medicine Precision Cancer Diagnostic Tests Major Product Offerings
7.13.4 Foundation Medicine Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.13.5 Foundation Medicine Key News
7.14 General Electric Company
7.14.1 General Electric Company Corporate Summary
7.14.2 General Electric Company Business Overview
7.14.3 General Electric Company Precision Cancer Diagnostic Tests Major Product Offerings
7.14.4 General Electric Company Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.14.5 General Electric Company Key News
7.15 Genomic Health
7.15.1 Genomic Health Corporate Summary
7.15.2 Genomic Health Business Overview
7.15.3 Genomic Health Precision Cancer Diagnostic Tests Major Product Offerings
7.15.4 Genomic Health Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.15.5 Genomic Health Key News
7.16 Hologic
7.16.1 Hologic Corporate Summary
7.16.2 Hologic Business Overview
7.16.3 Hologic Precision Cancer Diagnostic Tests Major Product Offerings
7.16.4 Hologic Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.16.5 Hologic Key News
7.17 Illumina
7.17.1 Illumina Corporate Summary
7.17.2 Illumina Business Overview
7.17.3 Illumina Precision Cancer Diagnostic Tests Major Product Offerings
7.17.4 Illumina Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.17.5 Illumina Key News
7.18 Menarini Silicon Biosystems SpA
7.18.1 Menarini Silicon Biosystems SpA Corporate Summary
7.18.2 Menarini Silicon Biosystems SpA Business Overview
7.18.3 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Major Product Offerings
7.18.4 Menarini Silicon Biosystems SpA Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.18.5 Menarini Silicon Biosystems SpA Key News
7.19 Myriad Genetics
7.19.1 Myriad Genetics Corporate Summary
7.19.2 Myriad Genetics Business Overview
7.19.3 Myriad Genetics Precision Cancer Diagnostic Tests Major Product Offerings
7.19.4 Myriad Genetics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.19.5 Myriad Genetics Key News
7.20 NanoString Technologies
7.20.1 NanoString Technologies Corporate Summary
7.20.2 NanoString Technologies Business Overview
7.20.3 NanoString Technologies Precision Cancer Diagnostic Tests Major Product Offerings
7.20.4 NanoString Technologies Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.20.5 NanoString Technologies Key News
7.21 Ortho Clinical Diagnostics
7.21.1 Ortho Clinical Diagnostics Corporate Summary
7.21.2 Ortho Clinical Diagnostics Business Overview
7.21.3 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
7.21.4 Ortho Clinical Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.21.5 Ortho Clinical Diagnostics Key News
7.22 QIAGEN N.V.
7.22.1 QIAGEN N.V. Corporate Summary
7.22.2 QIAGEN N.V. Business Overview
7.22.3 QIAGEN N.V. Precision Cancer Diagnostic Tests Major Product Offerings
7.22.4 QIAGEN N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.22.5 QIAGEN N.V. Key News
7.23 Randox Laboratories Ltd.
7.23.1 Randox Laboratories Ltd. Corporate Summary
7.23.2 Randox Laboratories Ltd. Business Overview
7.23.3 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Major Product Offerings
7.23.4 Randox Laboratories Ltd. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.23.5 Randox Laboratories Ltd. Key News
7.24 Roche Holding AG
7.24.1 Roche Holding AG Corporate Summary
7.24.2 Roche Holding AG Business Overview
7.24.3 Roche Holding AG Precision Cancer Diagnostic Tests Major Product Offerings
7.24.4 Roche Holding AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.24.5 Roche Holding AG Key News
7.25 Royal Philips N.V.
7.25.1 Royal Philips N.V. Corporate Summary
7.25.2 Royal Philips N.V. Business Overview
7.25.3 Royal Philips N.V. Precision Cancer Diagnostic Tests Major Product Offerings
7.25.4 Royal Philips N.V. Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.25.5 Royal Philips N.V. Key News
7.26 Siemens AG
7.26.1 Siemens AG Corporate Summary
7.26.2 Siemens AG Business Overview
7.26.3 Siemens AG Precision Cancer Diagnostic Tests Major Product Offerings
7.26.4 Siemens AG Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.26.5 Siemens AG Key News
7.27 Thermo Fisher Scientific
7.27.1 Thermo Fisher Scientific Corporate Summary
7.27.2 Thermo Fisher Scientific Business Overview
7.27.3 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Major Product Offerings
7.27.4 Thermo Fisher Scientific Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.27.5 Thermo Fisher Scientific Key News
7.28 Vela Diagnostics
7.28.1 Vela Diagnostics Corporate Summary
7.28.2 Vela Diagnostics Business Overview
7.28.3 Vela Diagnostics Precision Cancer Diagnostic Tests Major Product Offerings
7.28.4 Vela Diagnostics Precision Cancer Diagnostic Tests Revenue in Global Market (2017-2022)
7.28.5 Vela Diagnostics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer